<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Why This Biotech Company Could Be a Growth Stock Powerhouse — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Why This Biotech Company Could Be a Growth Stock Powerhouse</h2>
    <div class="badge">2025-09-17T09:10:00+00:00</div>
    <ul>
      <li>But, back in 2019, Vertex won approval for Trikafta, a treatment that may be used for up to 90% of CF patients.</li>
<li>if you invested $1,000 at the time of our recommendation, you’d have $648,369 !* Or when Nvidia made this list on April 15, 2005...</li>
<li>if you invested $1,000 at the time of our recommendation, you’d have $1,089,583 !* Now, it’s worth noting Stock Advisor’s total average return is 1,060 % — a market-crushing outperformance compared to 189% for the S&amp;P 50</li>
<li>Consider when Netflix made this list on December 17, 2004...</li>
<li>(Vertex also has rewarded long-term investors, as the stock has climbed about 190% over the past decade.) VRTX Revenue (Annual) Chart VRTX Revenue (Annual) data by YCharts In CF, symptoms are caused by a malfunctioning p</li>
<li>The 10 stocks that made the cut could produce monster returns in the coming years.</li>
<li>Don’t miss out on the latest top 10 list, available when you join Stock Advisor .</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Why%20This%20Biotech%20Company%20Could%20Be%20a%20Growth%20Stock%20Powerhouse%0A%E2%80%A2%20But%2C%20back%20in%202019%2C%20Vertex%20won%20approval%20for%20Trikafta%2C%20a%20treatment%20that%20may%20be%20used%20for%20up%20to%2090%25%20of%20CF%20patients.%0A%E2%80%A2%20if%20you%20invested%20%241%2C000%20at%20the%20time%20of%20our%20recommendation%2C%20you%E2%80%99d%20have%20%24648%2C369%20%21%2A%20Or%20when%20Nvidia%20made%20this%20list%20on%20April%2015%2C%202005...%0A%E2%80%A2%20if%20you%20invested%20%241%2C000%20at%20the%20time%20of%20our%20recommendation%2C%20you%E2%80%99d%20have%20%241%2C089%2C583%20%21%2A%20Now%2C%20it%E2%80%99s%20worth%20noting%20Stock%20Advisor%E2%80%99s%20total%20average%20return%20is%201%2C060%20%25%20%E2%80%94%20a%20market-crushing%20outperformance%20compared%20to%20189%25%20for%20the%20S%26P%2050%0A%E2%80%A2%20Consider%20when%20Netflix%20made%20this%20list%20on%20December%2017%2C%202004...%0A%E2%80%A2%20%28Vertex%20also%20has%20rewarded%20long-term%20investors%2C%20as%20the%20stock%20has%20climbed%20about%20190%25%20over%20the%20past%20decade.%29%20VRTX%20Revenue%20%28Annual%29%20Chart%20VRTX%20Revenue%20%28Annual%29%20data%20by%20YCharts%20In%20CF%2C%20symptoms%20are%20caused%20by%20a%20malfunctioning%20p%0A%E2%80%A2%20The%2010%20stocks%20that%20made%20the%20cut%20could%20produce%20monster%20returns%20in%20the%20coming%20years.%0A%E2%80%A2%20Don%E2%80%99t%20miss%20out%20on%20the%20latest%20top%2010%20list%2C%20available%20when%20you%20join%20Stock%20Advisor%20.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fwhy-this-biotech-company-could-be-a-growth-stock-powerhouse%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/m/77236724-cf23-396f-8090-677de39b0035/why-this-biotech-company.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>